T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
1976
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $516K | ﹤0.01% |
8,705
+4,455
| +105% | +$302K |
|
|
CTB
1977
DELISTED
Cooper Tire & Rubber Co.
CTB
| $516K | ﹤0.01% |
31,662
+6,910
| +28% | +$172K |
|
1978
Adient
ADNT
$1.54B
| $515K | ﹤0.01% |
56,779
+20,310
| +56% | +$409K |
|
1979
The RMR Group
RMR
$346M
| $515K | ﹤0.01% |
19,111
+1,826
| +11% | +$70.7K |
|
1980
Axcelis
ACLS
$4.42B
| $514K | ﹤0.01% |
28,054
-3,857
| -12% | -$89.6K |
|
1981
BridgeBio Pharma
BBIO
$15.9B
| $514K | ﹤0.01% |
+17,711
| New | +$549K |
|
1982
National Grid
NGG
$81.6B
| $509K | ﹤0.01% |
9,866
+1,153
| +13% | +$63.7K |
|
|
RAD
1983
DELISTED
Rite Aid Corporation
RAD
| $505K | ﹤0.01% |
33,657
-24,195
| -42% | -$338K |
|
|
UNIT
1984
Uniti Group
UNIT
$2.38B
| $504K | ﹤0.01% |
83,662
+39,699
| +90% | +$311K |
|
1985
Lennar Class B
LEN.B
$20.7B
| $501K | ﹤0.01% |
18,217
+12,308
| +208% | +$538K |
|
|
TRST
1986
Trustco Bank Corp NY
TRST
$971M
| $501K | ﹤0.01% |
18,512
+9,582
| +107% | +$348K |
|
|
LNW
1987
DELISTED
Light & Wonder
LNW
| $498K | ﹤0.01% |
51,310
+1,610
| +3% | +$32.9K |
|
1988
Group 1 Automotive
GPI
$3.14B
| $497K | ﹤0.01% |
11,236
+2,222
| +25% | +$187K |
|
1989
Century Aluminum
CENX
$4.59B
| $496K | ﹤0.01% |
137,073
+35,500
| +35% | +$199K |
|
1990
Fastly Inc
FSLY
$4.78B
| $495K | ﹤0.01% |
+26,060
| New | +$539K |
|
1991
Standard Motor Products
SMP
$870M
| $495K | ﹤0.01% |
11,900
+361
| +3% | +$17K |
|
1992
E.W. Scripps
SSP
$310M
| $493K | ﹤0.01% |
65,327
+1,865
| +3% | +$23K |
|
|
HEES
1993
DELISTED
H&E Equipment Services
HEES
| $492K | ﹤0.01% |
33,546
+3,931
| +13% | +$95.1K |
|
|
PDCE
1994
DELISTED
PDC Energy, Inc.
PDCE
| $492K | ﹤0.01% |
79,295
-464,242
| -85% | -$8.36M |
|
|
CLVS
1995
DELISTED
Clovis Oncology, Inc.
CLVS
| $492K | ﹤0.01% |
77,342
-8,085
| -9% | -$64.9K |
|
1996
TTEC Holdings
TTEC
$77.4M
| $491K | ﹤0.01% |
13,380
+1,886
| +16% | +$73.4K |
|
1997
Community Trust Bancorp
CTBI
$1.44B
| $490K | ﹤0.01% |
15,401
+3,323
| +28% | +$134K |
|
1998
Provident Financial Services
PFS
$3.26B
| $490K | ﹤0.01% |
38,064
+392
| +1% | +$7.96K |
|
1999
Universal Electronics
UEIC
$66.6M
| $490K | ﹤0.01% |
12,768
+1,320
| +12% | +$59.8K |
|
2000
Yext
YEXT
$613M
| $488K | ﹤0.01% |
47,868
-37,376
| -44% | -$536K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.